aTYR PHARMA (ATYR) Assets (2014 - 2026)
aTYR PHARMA's Assets was $69.83 million in Q2 2026, down 31.2% from $101.53 million a year earlier and down 12.3% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Assets at aTYR PHARMA came in at $93 million, down 4.0% from FY2024.
- Assets shows a five-year compound annual growth rate of 19.2% (FY2020 to FY2025).
- In earlier years, Assets was $96.83 million in FY2024 (-19.7%), $120.65 million in FY2023 (+26.0%), $95.79 million in FY2022 (-17.1%) and $115.54 million in FY2021 (+198.3%).
- The Q2 2026 figure marks the lowest quarterly Assets since Q2 2021.
- Compared with a year earlier, Assets has declined for three straight quarters, with an average decline of 12.7% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q4 2021 (growth of 198.3%); the worst was Q2 2026 (a decline of 31.2%).
- Per Business Quant data, ATYR's Assets in the three quarters before Q2 2026 was $79.65 million (Q1 2026), $93 million (Q4 2025) and $106.65 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | aTYR PHARMA | 16.86 Mn | -275.96 Mn | - | 69.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.83 Mn |
| Mar 31, 2026 | 79.65 Mn |
| Dec 31, 2025 | 93.00 Mn |
| Sep 30, 2025 | 106.65 Mn |
| Jun 30, 2025 | 101.53 Mn |
| Mar 31, 2025 | 97.25 Mn |
| Dec 31, 2024 | 96.83 Mn |
| Sep 30, 2024 | 91.62 Mn |
| Jun 30, 2024 | 105.94 Mn |
| Mar 31, 2024 | 113.25 Mn |
| Dec 31, 2023 | 120.65 Mn |
| Sep 30, 2023 | 125.07 Mn |
| Jun 30, 2023 | 132.75 Mn |
| Mar 31, 2023 | 136.84 Mn |
| Dec 31, 2022 | 95.79 Mn |
| Sep 30, 2022 | 96.06 Mn |
| Jun 30, 2022 | 96.02 Mn |
| Mar 31, 2022 | 104.78 Mn |
| Dec 31, 2021 | 115.54 Mn |
| Sep 30, 2021 | 123.92 Mn |
API Access
aTYR PHARMA Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();